Octane has announced that the Octane Neuro Tech Forum 2026 will take place March 26-27, 2026, at VEA Newport Beach, A Marriott Resort & Spa in Newport Beach, California. The event, part of Octane's Innovation Event Series, aims to bring together industry leaders, clinicians, investors, and entrepreneurs to advance innovation in neurotechnology.
The forum will feature keynote speaker Dr. Adnan Siddiqui, CEO and CMO of the Jacobs Institute, along with more than 30 expert speakers addressing emerging neurotech technologies, digital health innovation, brain-computer interfaces, and the evolving investment landscape. The agenda includes innovation panels, investor-focused sessions, company presentations, and networking opportunities designed to foster partnerships and accelerate development of next-generation neurotechnology solutions.
Octane fosters a future-focused ecosystem of tech and medtech companies across Southern California by connecting people, resources, and capital. Octane's mission is to drive innovation and growth by facilitating the exchange of ideas, knowledge, and resources that fuel the growth and development of Southern California's tech and medtech industries. Octane impacts the community through LaunchPad, a top-performing accelerator, Octane Capital & Growth, a platform to provide companies with capital and growth resources, Ignite Series, in-person and on-demand leading content and events, and Octane Foundation for Innovation, focused on furthering its mission while advancing diversity and inclusiveness.
The Neuro Tech Forum 2026 is expected to highlight the rapid advancements in neurotechnology, a field that holds promise for treating neurological disorders, enhancing cognitive function, and creating new interfaces between the brain and computers. With the aging population and increasing prevalence of conditions like Alzheimer's and Parkinson's disease, neurotechnology innovations are becoming more critical than ever. The forum provides a platform for stakeholders to discuss regulatory challenges, funding opportunities, and clinical applications.
For more information about Octane, visit www.octaneoc.org. To view the full press release, visit https://ibn.fm/43FAw.
